Press "Enter" to skip to content

Merck to buy cancer drug developer Peloton for $1.05 billion in cash

The company had been looking to go public and gave a pricing range of $15 to $17 per share for its initial public offering last week.

Original source: https://health.economictimes.indiatimes.com/news/pharma/merck-to-buy-cancer-drug-developer-peloton-for-1-05-billion-in-cash/69429324?utm_source=RSS&utm_medium=ETRSS

Also Read:   Doctors, cops to get vaccine on priority: Maharashtra minister